[Botulinum toxin: from drug to poison].
For most of its time, the history of botulinum toxin (BT) has been the history of botulism, i. e. of an intoxication with BT. By the end of the 1960's a paradigm shift took place which in this radicalness had never occurred before in the history of mankind. At that time BT was first used therapeutically to treat strabismus. From ophthalmology BT rapidly spread into numerous medical specialties. For most of its indications BT is the therapy of choice, for some it has revolutionized their treatment altogether. The widespread therapeutic use of BT allowed detailed clinical and technical investigations of BT's action upon the human body. Applying this knowledge we diagnosed for the first time chronic botulism in adults living on a farm with chronic bovine botulism. This constitutes another radical paradigm shift. The history of BT is the history of a dual paradigm shift each time induced by a complete reversal of the viewing perspective. Knowledge gain can be a linear process. It can, however, also be a circular one. Changes of the viewing perspective are crucial. Changing the viewing perspective may facilitate knowledge gain. This might be used to develop an instrument to facilitate knowledge gain.
Dressler
D
D
Klinik für Neurologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, Hannover. dressler.dirk@mh-hannover.de
Saberi
F A
FA
D000328:Adult; D000368:Aged; D000818:Animals; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000266:history / Q000506:poisoning* / Q000627:therapeutic use*; D001906:Botulism / Q000175:diagnosis* / Q000662:veterinary; D002417:Cattle; D002418:Cattle Diseases / Q000175:diagnosis; D005260:Female; D049673:History, 20th Century; D006801:Humans; D008297:Male; D008875:Middle Aged; D013285:Strabismus / Q000188:drug therapy
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins